Yes, Vyvanse is an amphetamine. Its active ingredient, lisdexamfetamine, is a prodrug that your body converts into dextroamphetamine, one of the most well-studied amphetamine compounds. The distinction is that Vyvanse isn’t active amphetamine when you swallow it. It only becomes amphetamine after a specific biological process takes place inside your body.
How Vyvanse Becomes Amphetamine
Lisdexamfetamine is created by chemically bonding dextroamphetamine to an amino acid called l-lysine. In this bonded form, the drug is pharmacologically inactive, meaning it has no stimulant effect on its own. After you take it orally, enzymes in your red blood cells gradually cleave the bond between the amphetamine and the lysine. This enzymatic step is the bottleneck in the process, and it’s what makes Vyvanse fundamentally different from taking amphetamine directly.
Because conversion happens at a controlled, enzyme-limited rate, the active dextroamphetamine enters your system gradually rather than all at once. This produces more predictable, steady drug levels throughout the day. It also means that taking a larger dose doesn’t proportionally speed up the conversion. The enzyme can only work so fast.
How Long the Effects Last
The slow conversion translates into a long duration of action. In clinical studies, Vyvanse improved attention starting around 2 hours after a dose in adults and lasting up to 14 hours. In children ages 6 to 12, effects began within 1.5 hours and lasted up to 13 hours. Peak blood levels of dextroamphetamine are reached about 3.5 to 4.5 hours after taking it.
This extended timeline is one of the main practical advantages. Many people taking Vyvanse for ADHD find that a single morning dose covers the full school or work day without needing a second pill in the afternoon.
Vyvanse vs. Adderall
Both Vyvanse and Adderall are amphetamine-based medications, but their composition differs. Adderall contains a mixture of four amphetamine salts, including both dextroamphetamine and a related compound called levoamphetamine. These are often referred to as “mixed amphetamine salts.” Vyvanse, by contrast, delivers only dextroamphetamine after conversion, with no levoamphetamine component.
The other key difference is delivery. Adderall (in its immediate-release form) delivers active amphetamine right away, producing a faster onset and a shorter window of effect. Adderall XR uses a bead-based extended-release system to stretch that window. Vyvanse achieves its extended duration through the prodrug mechanism itself, not through a physical delivery system in the capsule. This means you can open a Vyvanse capsule and mix it with water or food without changing how the drug is absorbed, something that would compromise many extended-release formulations.
What Vyvanse Is Approved to Treat
The FDA has approved Vyvanse for two conditions. The first is ADHD in patients age 6 and older, including adults. The second is moderate to severe binge eating disorder in adults only. It is not approved for weight loss on its own, and it has not been studied in children under 6.
Why the Prodrug Design Matters for Misuse
Stimulant medications carry a risk of misuse, and the prodrug design of Vyvanse was specifically engineered to reduce that risk. When someone misuses a stimulant, the goal is typically a rapid, intense surge of the drug in the brain. Crushing, snorting, or injecting a standard amphetamine pill can achieve that. With Vyvanse, those routes don’t work the same way. Because the drug requires enzymatic conversion by red blood cells regardless of how it enters the body, the rate of active amphetamine release stays relatively consistent whether it’s swallowed, snorted, or injected.
This doesn’t eliminate misuse potential entirely. Vyvanse is still a Schedule II controlled substance, the same category as Adderall and other amphetamines. But the built-in speed limit on conversion makes it harder to produce the rapid high that drives most stimulant misuse.
Side Effects Follow the Amphetamine Profile
Because Vyvanse ultimately delivers dextroamphetamine, its side effects are consistent with what you’d expect from any amphetamine stimulant. The most common include decreased appetite, trouble sleeping, dry mouth, increased heart rate, and irritability. These tend to be most noticeable when you first start the medication or after a dose increase, and they often become more manageable over time.
Since amphetamines raise heart rate and blood pressure, people with certain cardiovascular conditions need careful evaluation before starting Vyvanse. The appetite suppression can be significant, particularly in children, which is why growth monitoring is a standard part of treatment for younger patients.
The Short Answer
Vyvanse is not amphetamine in the capsule, but it is amphetamine in your bloodstream. Every milligram of therapeutic effect comes from dextroamphetamine, released gradually as your red blood cells do the conversion work. The prodrug wrapper changes the timing and abuse profile, but the active drug doing the work in your brain is the same compound found in other amphetamine medications.